| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
RNA
|
Prior to Jul 01, 2017 |
|||||||
| GSM1678901 |
Reference without treatment - Replicate1
|
RNA | 1 | shah saddad Hussain | Jun 30, 2017 | ||||
| GSM1678902 |
Reference without treatment - Replicate2
|
RNA | 1 | shah saddad Hussain | Jun 30, 2017 | ||||
| GSM1678903 |
Reference without treatment - Replicate3
|
RNA | 1 | shah saddad Hussain | Jun 30, 2017 | ||||
| GSM1678904 |
Reference without treatment - Replicate4
|
RNA | 1 | shah saddad Hussain | Jun 30, 2017 | ||||
| GSM1678905 |
Rat treated with Pregnant Mare Serum Gonadotropins (PMSG) - Replicate1
|
RNA | 1 | shah saddad Hussain | Jun 30, 2017 | ||||
| GSM1678906 |
Rat treated with Pregnant Mare Serum Gonadotropins (PMSG) - Replicate2
|
RNA | 1 | shah saddad Hussain | Jun 30, 2017 | ||||
| GSM1678907 |
Rat treated with Pregnant Mare Serum Gonadotropins (PMSG) - Replicate3
|
RNA | 1 | shah saddad Hussain | Jun 30, 2017 | ||||
| GSM1678909 |
Rat treated with Pregnant Mare Serum Gonadotropins (PMSG) - Replicate4
|
RNA | 1 | shah saddad Hussain | Jun 30, 2017 | ||||
| GSM1709127 |
anti-miR-182 treatment, day2 after IRI, R102L
|
RNA | 1 | Julia Wilflingseder | Jun 30, 2017 | ||||
| GSM1709128 |
anti-miR-182 treatment, day2 after IRI, R103L
|
RNA | 1 | Julia Wilflingseder | Jun 30, 2017 | ||||
| GSM1709129 |
anti-miR-182 treatment, day2 after IRI, R95L
|
RNA | 1 | Julia Wilflingseder | Jun 30, 2017 | ||||
| GSM1709130 |
placebo treatment, day2 after IRI, R101L
|
RNA | 1 | Julia Wilflingseder | Jun 30, 2017 | ||||
| GSM1709131 |
placebo treatment, day2 after IRI, R93L
|
RNA | 1 | Julia Wilflingseder | Jun 30, 2017 | ||||
| GSM1709132 |
placebo treatment, day2 after IRI, R96L
|
RNA | 1 | Julia Wilflingseder | Jun 30, 2017 | ||||
| GSM1815529 |
anti-miR-182 treatment, day7 after IRI, R61L
|
RNA | 1 | Julia Wilflingseder | Jun 30, 2017 | ||||
| GSM1815530 |
anti-miR-182 treatment, day7 after IRI, R77L
|
RNA | 1 | Julia Wilflingseder | Jun 30, 2017 | ||||
| GSM1815531 |
anti-miR-182 treatment, day7 after IRI, R99L
|
RNA | 1 | Julia Wilflingseder | Jun 30, 2017 | ||||
| GSM1815532 |
placebo treatment, day7 after IRI, R100L
|
RNA | 1 | Julia Wilflingseder | Jun 30, 2017 | ||||
| GSM1815533 |
placebo treatment, day7 after IRI, R37L
|
RNA | 1 | Julia Wilflingseder | Jun 30, 2017 | ||||
| GSM1815534 |
placebo treatment, day7 after IRI, R50L
|
RNA | 1 | Julia Wilflingseder | Jun 30, 2017 |
